Philippe Flandre

Accuracy of predictive ability measures for survival models.

John O'Quigley, Philippe Flandre, Reena Deutsch, 2017, Statistics in medicine.

Investigation of Super Learner Methodology on HIV-1 Small Sample: Application on Jaguar Trial Data

Philippe Flandre, Vincent Calvez, Jean Michel Molina, 2012, AIDS research and treatment.

Factors Associated with the Selection of Mutations Conferring Resistance to Protease Inhibitors (PIs) in PI-Experienced Patients Displaying Treatment Failure on Darunavir

Philippe Flandre, Vincent Calvez, Christine Katlama, 2007, Antimicrobial Agents and Chemotherapy.

Tipranavir-Ritonavir Genotypic Resistance Score in Protease Inhibitor-Experienced Patients

Philippe Flandre, Vincent Calvez, Jacques Izopet, 2008, Antimicrobial Agents and Chemotherapy.

Genotypic resistance analyses in nucleoside-pretreated patients failing an indinavir containing regimen: results from a randomized comparative trial: (Novavir ANRS 073).

Philippe Flandre, Françoise Brun-Vézinet, Diane Descamps, 2005, Journal of clinical virology : the official publication of the Pan American Society for Clinical Virology.

Lopinavir/ritonavir monotherapy or plus zidovudine and lamivudine in antiretroviral-naive HIV-infected patients

Philippe Flandre, Pierre-Marie Girard, C. Delaugerre, 2008, AIDS.

An evaluation of HIV RNA and CD4 cell count as surrogates for clinical outcome. Delta Coordinating Committee and Virology Group.

Abdel Babiker, Philippe Flandre, Peter Reiss, 1999, AIDS.

Nevirapine or lamivudine plus stavudine and indinavir: examples of 2-class versus 3-class regimens for the treatment of human immunodeficiency virus type 1.

Philippe Flandre, Stéphane Rivet, Jean-Pierre Aboulker, 2002, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.